Rebeca Piatniczka Iglesia in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Glioblastoma multiforme (GBM), the most aggressive type of brain tumor, is initiated and maintained by a subpopulation of tumorigenic cells called glioblastoma stem cells (GSCs) that contribute to progression and resistance to therapy. In GBM therapy the alkylating agent temozolomide (TMZ) is the most effective chemotherapist, but resistance is frequent. One of the mechanisms of resistanc…
Glioblastomas (GBM) are highly lethal brain tumors, which contains a subpopulation of Glioblastoma Stem Cells (GSC) capable of promoting tumor angiogenesis, invasion and radiotherapy and chemotherapy resistance, contributing to the failure to treat these cancers. Studies show that the interaction of two proteins, the cellular prion protein (PrPC) and stress inducible protein 1 (STI1), pro…
The cellular prion protein, a glycoprotein abundantly expressed in central nervous system (CNS), present neurotrophic potential through the formation of multiprotein complexes with several ligands on the cell surface. Glioblastoma, a type of CNS tumor, extremely aggressive and 100% lethal, contains a subpopulation of cells responsible for therapy resistance, the glioblastoma stem cells (G…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID